A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 12,006 shares of RCKT stock, worth $122,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,006
Previous 13,118 8.48%
Holding current value
$122,581
Previous $282,000 21.63%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$17.6 - $25.88 $19,571 - $28,778
-1,112 Reduced 8.48%
12,006 $221,000
Q2 2024

Aug 12, 2024

BUY
$20.66 - $26.72 $45,803 - $59,238
2,217 Added 20.34%
13,118 $282,000
Q1 2024

May 09, 2024

SELL
$26.16 - $30.74 $12,792 - $15,031
-489 Reduced 4.29%
10,901 $293,000
Q4 2023

Feb 08, 2024

SELL
$16.78 - $31.94 $35,019 - $66,658
-2,087 Reduced 15.49%
11,390 $341,000
Q3 2023

Nov 07, 2023

BUY
$15.07 - $24.05 $14,783 - $23,593
981 Added 7.85%
13,477 $276,000
Q2 2023

Aug 09, 2023

SELL
$16.59 - $23.6 $64,634 - $91,945
-3,896 Reduced 23.77%
12,496 $248,000
Q1 2023

May 08, 2023

BUY
$15.79 - $22.6 $15,363 - $21,989
973 Added 6.31%
16,392 $280,000
Q4 2022

Feb 07, 2023

SELL
$15.5 - $22.76 $151,683 - $222,729
-9,786 Reduced 38.83%
15,419 $301,000
Q3 2022

Nov 01, 2022

BUY
$12.37 - $18.41 $5,492 - $8,174
444 Added 1.79%
25,205 $402,000
Q2 2022

Aug 04, 2022

BUY
$7.96 - $16.64 $105,072 - $219,648
13,200 Added 114.18%
24,761 $341,000
Q1 2022

May 09, 2022

BUY
$13.16 - $23.68 $12,265 - $22,069
932 Added 8.77%
11,561 $183,000
Q4 2021

Feb 07, 2022

BUY
$21.52 - $36.02 $65,485 - $109,608
3,043 Added 40.11%
10,629 $252,000
Q3 2021

Nov 04, 2021

BUY
$27.42 - $48.97 $5,785 - $10,332
211 Added 2.86%
7,586 $227,000
Q2 2021

Aug 06, 2021

SELL
$39.41 - $47.25 $129,540 - $155,310
-3,287 Reduced 30.83%
7,375 $327,000
Q1 2021

May 06, 2021

BUY
$43.34 - $65.91 $152,773 - $232,332
3,525 Added 49.39%
10,662 $473,000
Q4 2020

Feb 09, 2021

SELL
$23.3 - $59.57 $69,853 - $178,590
-2,998 Reduced 29.58%
7,137 $391,000
Q3 2020

Nov 10, 2020

BUY
$20.5 - $28.59 $2,357 - $3,287
115 Added 1.15%
10,135 $232,000
Q2 2020

Aug 06, 2020

SELL
$13.32 - $22.61 $20,539 - $34,864
-1,542 Reduced 13.34%
10,020 $210,000
Q1 2020

May 11, 2020

BUY
$9.71 - $25.11 $23,274 - $60,188
2,397 Added 26.15%
11,562 $161,000
Q4 2019

Feb 05, 2020

BUY
$11.07 - $24.23 $7,892 - $17,275
713 Added 8.44%
9,165 $204,000
Q3 2019

Nov 12, 2019

BUY
$10.85 - $14.78 $17,197 - $23,426
1,585 Added 23.08%
8,452 $98,000
Q2 2019

Aug 08, 2019

SELL
$15.0 - $19.81 $62,190 - $82,132
-4,146 Reduced 37.65%
6,867 $103,000
Q1 2019

Apr 26, 2019

BUY
$13.45 - $19.01 $10,948 - $15,474
814 Added 7.98%
11,013 $193,000
Q4 2018

Feb 08, 2019

BUY
$11.21 - $23.53 $40,333 - $84,660
3,598 Added 54.51%
10,199 $153,000
Q3 2018

Nov 13, 2018

BUY
$18.5 - $25.49 $122,118 - $168,259
6,601 New
6,601 $163,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $773M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.